Opiant Pharmaceuticals, Inc. SC 13G and SC 13G/A reports

Location
233 Wilshire Blvd, Suite 400, Santa Monica, CA
Fiscal year end
December 31
Data updated at
7/19/2024, 08:54 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Feb 15, 2023
SC 13G Report SC 13G Nov 28, 2022
SC 13G/A Report Feb 10, 2022
SC 13G/A Report Jan 27, 2022
SC 13G/A Report AMENDMENT NO. 2 TO THE SCHEDULE 13G Feb 16, 2021
SC 13G/A Report Feb 12, 2021
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 11, 2021
SC 13G Report Feb 11, 2021
SC 13G Report Feb 10, 2021
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 14, 2020
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2020
SC 13G/A Report Feb 13, 2020
SC 13G Report Jul 8, 2019
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Jun 5, 2019
SC 13G/A Report Feb 13, 2019
SC 13G Report Oct 9, 2018
SC 13G Report SCHEDULE 13G Sep 14, 2018